10-Q Filing

ACUTUS MEDICAL, INC. CIK: 1522860 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001628280-21-023217`
Period End Date	20210930
Filing Date	20211112
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	afib-20210930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 84 Cash Flow Statement 95 Stockholders Equity 50

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$58.49M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.23M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	6,666.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	6,666.00	shares	Point-in-time
Marketable securities, short-term	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$105.84M	USD	Point-in-time
Marketable securities, short-term	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$71.96M	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$150.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$150.00K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$2.16M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$4.19M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Inventory	`InventoryNet`	$14.96M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	27.99M	shares	Point-in-time
Inventory	`InventoryNet`	$12.96M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	27.95M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	27.95M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.05M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	26.72M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	27.99M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.04M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$151.39M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$155.80M	USD	Point-in-time
Marketable securities, long-term	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$4.06M	USD	Point-in-time
Marketable securities, long-term	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$8.73M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$14.60M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.36M	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$1.67M	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$4.68M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.17M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.65M	USD	Point-in-time
Goodwill	`Goodwill`	$12.03M	USD	Point-in-time
Goodwill	`Goodwill`	$12.03M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.09M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$717.00K	USD	Point-in-time
Total assets	`Assets`	$192.53M	USD	Point-in-time
Total assets	`Assets`	$197.42M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.27M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.42M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$9.40M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$7.31M	USD	Point-in-time
Contingent consideration, short-term	`ShorttermContingentConsideration`	$1.90M	USD	Point-in-time
Contingent consideration, short-term	`ShorttermContingentConsideration`	$5.40M	USD	Point-in-time
Operating lease liabilities, short-term	`OperatingLeaseLiabilityCurrent`	$466.00K	USD	Point-in-time
Operating lease liabilities, short-term	`OperatingLeaseLiabilityCurrent`	$933.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$21.91M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.18M	USD	Point-in-time
Operating lease liabilities, long-term	`OperatingLeaseLiabilityNoncurrent`	$4.70M	USD	Point-in-time
Operating lease liabilities, long-term	`OperatingLeaseLiabilityNoncurrent`	$1.13M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$40.04M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$39.01M	USD	Point-in-time
Contingent consideration, long-term	`LongtermContingentConsideration`	$800.00K	USD	Point-in-time
Contingent consideration, long-term	`LongtermContingentConsideration`	$3.90M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$18.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$65.95M	USD	Point-in-time
Total liabilities	`Liabilities`	$63.74M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized as of September 30, 2021 and December 31, 2020; 6,666 shares of the preferred stock, designated as Series A Common Equivalent Preferred Stock, are issued and outstanding as of September 30, 2021, no shares issued and outstanding as of December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized as of September 30, 2021 and December 31, 2020; 6,666 shares of the preferred stock, designated as Series A Common Equivalent Preferred Stock, are issued and outstanding as of September 30, 2021, no shares issued and outstanding as of December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 260,000,000 shares authorized as of September 30, 2021 and December 31, 2020; 27,948,653 and 27,991,425 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$28.00K	USD	Point-in-time
Common stock, $0.001 par value; 260,000,000 shares authorized as of September 30, 2021 and December 31, 2020; 27,948,653 and 27,991,425 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$28.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$581.13M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$487.29M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-447.43M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-361.01M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-40.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$280.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-263.97M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.86M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$126.58M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$152.64M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$133.69M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$192.53M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$197.42M	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.17M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$5.89M	USD	3 Qtrs
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$4.60M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$12.90M	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$8.54M	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$22.99M	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$11.00M	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$5.14M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$9.30M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$27.84M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$8.34M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$24.49M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$47.66M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$35.19M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$15.83M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$15.80M	USD	1 Quarter
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$-1.95M	USD	1 Quarter
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$-1.47M	USD	3 Qtrs
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$-3.36M	USD	3 Qtrs
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$118.00K	USD	1 Quarter
Total costs and operating expenses	`OperatingCostsAndExpenses`	$31.69M	USD	1 Quarter
Total costs and operating expenses	`OperatingCostsAndExpenses`	$29.43M	USD	1 Quarter
Total costs and operating expenses	`OperatingCostsAndExpenses`	$95.12M	USD	3 Qtrs
Total costs and operating expenses	`OperatingCostsAndExpenses`	$69.22M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-27.09M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-26.26M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-63.33M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-82.22M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$3.68M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$5.55M	USD	3 Qtrs
Interest income	`InterestAndOtherIncome`	$23.00K	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$88.00K	USD	3 Qtrs
Interest income	`InterestAndOtherIncome`	$19.00K	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$393.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.37M	USD	1 Quarter
Interest expense	`InterestExpense`	$4.29M	USD	3 Qtrs
Interest expense	`InterestExpense`	$4.09M	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.44M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-9.25M	USD	3 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-5.03M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-1.42M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-4.20M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-86.42M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-28.51M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-72.58M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-31.29M	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-31.29M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-72.58M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-86.42M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-28.51M	USD	1 Quarter
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-13.00K	USD	1 Quarter
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-9.00K	USD	1 Quarter
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-3.00K	USD	3 Qtrs
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-50.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-183.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-317.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$78.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$147.00K	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-72.48M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-28.71M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-31.22M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-86.74M	USD	3 Qtrs
Net loss per common share, basic (in dollars per share)	`EarningsPerShareBasic`	$-2.99	USD	3 Qtrs
Net loss per common share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.94	USD	1 Quarter
Net loss per common share, basic (in dollars per share)	`EarningsPerShareBasic`	$-1.95	USD	1 Quarter
Net loss per common share, basic (in dollars per share)	`EarningsPerShareBasic`	$-12.36	USD	3 Qtrs
Net loss per common share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.94	USD	1 Quarter
Net loss per common share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-2.99	USD	3 Qtrs
Net loss per common share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-12.36	USD	3 Qtrs
Net loss per common share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.95	USD	1 Quarter
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	5.87M	shares	3 Qtrs
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	28.89M	shares	3 Qtrs
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	16.08M	shares	1 Quarter
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	30.46M	shares	1 Quarter
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.87M	shares	3 Qtrs
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	16.08M	shares	1 Quarter
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.46M	shares	1 Quarter
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	28.89M	shares	3 Qtrs

Cash Flow Statement 95 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-72.58M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-86.42M	USD	3 Qtrs
Depreciation expense	`Depreciation`	$4.23M	USD	3 Qtrs
Depreciation expense	`Depreciation`	$1.75M	USD	3 Qtrs
Depreciation expense	`Depreciation`	$800.00K	USD	1 Quarter
Depreciation expense	`Depreciation`	$1.50M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$330.00K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$100.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$480.00K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$200.00K	USD	1 Quarter
Non-cash stock-based compensation expense	`ShareBasedCompensation`	$10.26M	USD	3 Qtrs
Non-cash stock-based compensation expense	`ShareBasedCompensation`	$9.27M	USD	3 Qtrs
Amortization of premiums on marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.01M	USD	3 Qtrs
Amortization of premiums on marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-113.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$518.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.03M	USD	3 Qtrs
Amortization of right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$496.00K	USD	3 Qtrs
Amortization of right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$507.00K	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$3.68M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$5.55M	USD	3 Qtrs
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$-1.47M	USD	3 Qtrs
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$-3.36M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.63M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.03M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$2.00M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$1.86M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$59.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.73M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$387.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$369.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$753.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.81M	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.86M	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.42M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-615.00K	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-432.00K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$18.00K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$8.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-61.04M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-77.10M	USD	3 Qtrs
Purchases of available-for-sale marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$70.02M	USD	3 Qtrs
Purchases of available-for-sale marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$108.53M	USD	3 Qtrs
Sales of available-for-sale marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$17.09M	USD	3 Qtrs
Sales of available-for-sale marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$8.59M	USD	3 Qtrs
Maturities of available-for-sale marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$98.51M	USD	3 Qtrs
Maturities of available-for-sale marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$45.00M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$6.59M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.82M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-54.26M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$30.49M	USD	3 Qtrs
Payment of deferred offering costs	`PaymentsOfFinancingCosts`	$572.00K	USD	3 Qtrs
Payment of deferred offering costs	`PaymentsOfFinancingCosts`	-	USD	3 Qtrs
Payment of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$2.64M	USD	3 Qtrs
Payment of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$3.15M	USD	3 Qtrs
Proceeds from the issuance of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$166.29M	USD	3 Qtrs
Proceeds from the issuance of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$82.70M	USD	Point-in-time
Proceeds from the issuance of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$82.66M	USD	3 Qtrs
Proceeds from stock options exercises	`ProceedsFromStockOptionsExercised`	$703.00K	USD	3 Qtrs
Proceeds from stock options exercises	`ProceedsFromStockOptionsExercised`	$350.00K	USD	3 Qtrs
Proceeds from employee stock purchase plan	`ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans`	-	USD	3 Qtrs
Proceeds from employee stock purchase plan	`ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans`	$440.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$164.00M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$80.08M	USD	3 Qtrs
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-214.00K	USD	3 Qtrs
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$143.00K	USD	3 Qtrs
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$48.85M	USD	3 Qtrs
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$33.26M	USD	3 Qtrs
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.38M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$58.45M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$58.64M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.38M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$58.45M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$58.64M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaidNet`	-	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaidNet`	$38.00K	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$3.53M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$3.11M	USD	3 Qtrs
Issuance of Series D convertible preferred stock for Biotronik asset purchase	`IssuanceOfSeriesDConvertiblePreferredStockForBiotroniksAssetPurchase`	-	USD	3 Qtrs
Issuance of Series D convertible preferred stock for Biotronik asset purchase	`IssuanceOfSeriesDConvertiblePreferredStockForBiotroniksAssetPurchase`	$5.00M	USD	3 Qtrs
Issuance of Series D convertible preferred stock for Rhythm Xience Acquisition	`IssuanceOfSeriesDConvertiblePreferredStockForRhythmXienceAcquisition`	$2.20M	USD	3 Qtrs
Issuance of Series D convertible preferred stock for Rhythm Xience Acquisition	`IssuanceOfSeriesDConvertiblePreferredStockForRhythmXienceAcquisition`	-	USD	3 Qtrs
Change in unrealized loss on marketable securities	`DebtSecuritiesUnrealizedGainLoss`	$-50.00K	USD	3 Qtrs
Change in unrealized loss on marketable securities	`DebtSecuritiesUnrealizedGainLoss`	$-3.00K	USD	3 Qtrs
Right-of-use assets exchanged for operating lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	3 Qtrs
Right-of-use assets exchanged for operating lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$3.53M	USD	3 Qtrs
Unpaid purchases of property and equipment	`UnpaidPurchasesOfPropertyPlantAndEquipment`	$88.00K	USD	3 Qtrs
Unpaid purchases of property and equipment	`UnpaidPurchasesOfPropertyPlantAndEquipment`	$36.00K	USD	3 Qtrs
Conversion of convertible preferred stock into common stock upon IPO	`ConversionOfStockAmountConverted1`	-	USD	3 Qtrs
Conversion of convertible preferred stock into common stock upon IPO	`ConversionOfStockAmountConverted1`	$260.56M	USD	3 Qtrs
Reclassification of warrant liability to stockholders' equity	`ReclassificationOfWarrantLiabilityToStockholdersEquity`	$14.47M	USD	3 Qtrs
Reclassification of warrant liability to stockholders' equity	`ReclassificationOfWarrantLiabilityToStockholdersEquity`	-	USD	3 Qtrs

Stockholders Equity 50 line items

Line Item	Tag	Value	Unit	Period
Issuance costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$16.36M	USD	1 Quarter
Issuance costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$16.36M	USD	3 Qtrs
Issuance costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$5.88M	USD	1 Quarter
Issuance costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$5.88M	USD	3 Qtrs
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-263.97M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.86M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$126.58M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$152.64M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$133.69M	USD	Point-in-time
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-13.00K	USD	1 Quarter
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-9.00K	USD	1 Quarter
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-3.00K	USD	3 Qtrs
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-50.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-183.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-317.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$78.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$147.00K	USD	3 Qtrs
Exchange of common stock for Series A Common Equivalent Preferred Stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	1 Quarter
Exchange of common stock for Series A Common Equivalent Preferred Stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$260.56M	USD	1 Quarter
Exchange of common stock for Series A Common Equivalent Preferred Stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	3 Qtrs
Exchange of common stock for Series A Common Equivalent Preferred Stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$260.56M	USD	3 Qtrs
Issuance of common stock for cash, net of issuance costs (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	6.33M	shares	Point-in-time
Issuance of common stock for cash, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$82.66M	USD	3 Qtrs
Issuance of common stock for cash, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$166.29M	USD	1 Quarter
Issuance of common stock for cash, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$166.29M	USD	3 Qtrs
Issuance of common stock for cash, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$82.66M	USD	1 Quarter
Reclassification of warrant liability to stockholders' equity	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$14.47M	USD	1 Quarter
Reclassification of warrant liability to stockholders' equity	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$14.47M	USD	3 Qtrs
Stock option exercises (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	110,421.00	shares	3 Qtrs
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$350.00K	USD	3 Qtrs
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$84.00K	USD	1 Quarter
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$145.00K	USD	1 Quarter
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$703.00K	USD	3 Qtrs
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$6.37M	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$3.35M	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$9.27M	USD	3 Qtrs
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$10.04M	USD	3 Qtrs
Employee stock purchase plan shares issued	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$440.00K	USD	3 Qtrs
Employee stock purchase plan shares issued	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$440.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-31.29M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-72.58M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-86.42M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-28.51M	USD	1 Quarter
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-263.97M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.86M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$126.58M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$152.64M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$133.69M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.